15 Frequently Asked Questions: Leukemia, Lymphoma and Blood Cancer Treatments in India for Nigerian Patients

Author:- Dr. Dheeraj Bojwani Date Created:- 05-09-2026

Introduction

Leukemia, lymphoma, multiple myeloma and other blood cancers require highly specialized diagnosis and treatment. Depending on the type and stage of disease, treatment may involve chemotherapy, targeted therapy, immunotherapy, radiation therapy, stem-cell or bone-marrow transplantation and, for selected patients, advanced cellular therapies such as CAR-T cell therapy. India has developed specialized hematology, hemato-oncology, bone-marrow transplant and cellular-therapy centres. Treatment is generally planned according to the patient's exact diagnosis, molecular profile, previous treatment, disease response, age and overall health. For Nigerian patients, treatment in India may provide access to specialist hematologists, advanced diagnostic facilities, transplantation programmes and newer treatment options.

Healing Journeys of Nigerian Patients

Nigerian Patients Share Their Experience

In Brief

Leukemia, lymphoma, multiple myeloma and other blood cancers require highly specialized diagnosis and treatment. Depending on the type and stage of disease, treatment may involve chemotherapy, targeted therapy, immunotherapy, radiation therapy, stem-cell or bone-marrow transplantation and, for selected patients, advanced cellular therapies such as CAR-T cell therapy. India has developed specialized hematology, hemato-oncology, bone-marrow transplant and cellular-therapy centres. Treatment is generally planned according to the patient's exact diagnosis, molecular profile, previous treatment, disease response, age and overall health.

Q1 · Why Do Nigerian Patients Consider Leukemia, Lymphoma and Blood Cancer Treatment in India?

Nigerian patients may consider India when they require specialized diagnosis or treatment for leukemia, lymphoma, multiple myeloma or other hematological malignancies.

Treatment options in India may include

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Bone-marrow transplantation
• Hematopoietic stem-cell transplantation
• Autologous stem-cell transplantation
• Allogeneic stem-cell transplantation
• Haploidentical transplantation
• CAR-T cell therapy for selected eligible patients
• Supportive and transfusion care
• Pediatric hematology and oncology
• Molecular and genetic testing

Patients may consider India because of

• Specialist hematologists and hemato-oncologists
• Dedicated blood cancer departments
• Advanced hematopathology laboratories
• Bone-marrow biopsy and flow cytometry
• Molecular and cytogenetic testing
• Specialized transplant units
• Advanced infection-control facilities
• Pediatric blood cancer programmes
• Cellular-therapy facilities at selected centres
• Multidisciplinary cancer care
• International-patient support

The appropriate treatment centre should be selected according to the exact blood cancer, treatment requirement, transplant eligibility and specialist expertise rather than cost alone.

Q2 · What Is the Cost of Leukemia, Lymphoma and Blood Cancer Treatment in India Compared With Nigeria?

Nigerian patients should compare the complete treatment cost rather than looking only at the chemotherapy, transplant or treatment fee.

The total cost depends on the type of blood cancer, disease stage, treatment protocol, medicines, hospitalization, complications, transplant requirement and whether advanced cellular therapy is required.

Exchange Rate Used

Approximate Leukemia, Lymphoma and Blood Cancer Treatment

Cost Comparison

Planning note: These are indicative medical-tourism planning ranges, not fixed hospital quotations. The final cost can change according to diagnosis, treatment protocol, medicines, complications, duration of hospitalization, transplant complexity and eligibility for cellular therapy.

Advanced hematology centres in India currently provide chemotherapy, hematopoietic stem-cell transplantation and cellular therapies, including CAR-T for selected blood cancers.

What Should Be Included in the Total Cost?

A Nigerian patient should ask the hospital whether the quotation includes:

• Hematologist consultation
• Hemato-oncologist consultation
• Diagnostic investigations
• Bone-marrow aspiration and biopsy
• Flow cytometry
• Immunophenotyping
• Molecular and cytogenetic testing
• Imaging where required
• Chemotherapy medicines
• Targeted medicines
• Immunotherapy
• Radiation therapy where required
• Stem-cell collection
• Donor evaluation
• HLA matching where required
• Conditioning therapy
• Stem-cell transplantation
• CAR-T therapy where applicable
• Hospital room
• ICU care if required
• Nursing care
• Blood and platelet transfusions
• Antibiotics and supportive medicines
• Infection management
• Management of treatment complications
• Follow-up consultations
• Post-treatment investigations
• Physiotherapy and nutritional support where required
• Accommodation outside the hospital
• Flights
• Visa expenses
• Travel insurance

Compare the Complete Treatment Cost

In Nigeria

The treatment journey may involve diagnosis, hematology consultation, chemotherapy or other systemic treatment, hospitalization, transfusions, management of complications and, when required, stem-cell transplantation or cellular therapy.

In India

The treatment journey may include remote medical-record review, specialist consultation, diagnostic confirmation, molecular testing, treatment planning, chemotherapy, targeted therapy, immunotherapy, transplantation or cellular therapy when appropriate, followed by monitoring and follow-up.

The final quotation should always be based on the patient's actual diagnosis and medical records.

Compare the full planned treatment journey, not only the treatment quotation.

Q3 · Which Indian Cities Are Best for Leukemia, Lymphoma and Blood Cancer Treatment for Nigerian Patients?

Choosing an Indian city should depend on the patient's diagnosis, required treatment, transplant requirement, specialist availability, hospital infrastructure and follow-up arrangements—not simply the lowest price.

Major Indian Cities for Leukemia, Lymphoma and Blood Cancer

Treatment

City Why Nigerian Patients May Consider It

Major hematology, hemato-oncology, bone-marrow transplant and advanced

The final city should be selected according to the patient's medical condition and the hospital and specialist providing appropriate treatment.

Q4 · Which Hospitals in India Treat Leukemia, Lymphoma and Other Blood Cancers?

India has a wide network of hospitals and specialized cancer centres offering hematology, hemato-oncology, chemotherapy, transplantation and advanced cellular therapies.

Hospital selection should be based on the patient's exact blood cancer, treatment requirement, transplant eligibility, specialist expertise and availability of advanced therapies.

Q5 · What Types of Leukemia, Lymphoma and Blood Cancer Treatments Are Available in India?

Treatment depends on the exact diagnosis, disease stage, molecular characteristics, previous treatment and overall health.

Leukemia Treatment

Treatment may include:

• Acute lymphoblastic leukemia (ALL) treatment
• Acute myeloid leukemia (AML) treatment
• Chronic lymphocytic leukemia (CLL) treatment
• Chronic myeloid leukemia (CML) treatment
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Maintenance therapy
• Stem-cell transplantation in selected cases
• CAR-T therapy for selected eligible patients

Lymphoma Treatment

Treatment may include:

• Hodgkin lymphoma treatment
• Non-Hodgkin lymphoma treatment
• B-cell lymphoma treatment
• T-cell lymphoma treatment
• Chemotherapy
• Immunotherapy
• Targeted therapy
• Radiation therapy
• Stem-cell transplantation
• CAR-T therapy for selected relapsed or refractory B-cell malignancies

Multiple Myeloma Treatment

Treatment may include:

• Combination drug therapy
• Targeted therapy
• Immunomodulatory medicines
• Proteasome inhibitors
• Monoclonal antibodies
• Autologous stem-cell transplantation
• Maintenance therapy
• Cellular therapies for selected eligible patients

Other Blood Cancers

Specialist centres may also manage:

• Myelodysplastic syndromes
• Myelofibrosis
• Chronic myelomonocytic leukemia
• Aplastic anemia
• Other complex hematological malignancies

Treatment must be selected according to the patient's confirmed diagnosis.

Q6 · How Can Nigerian Patients Get a Blood Cancer Treatment Quotation From India While Abroad?

Nigerian patients can begin the evaluation process before travelling by providing their complete medical records to an Indian hematology or hemato-oncology centre.

Important records may include

• Complete blood count
• Peripheral blood smear
• Bone-marrow aspiration report
• Bone-marrow biopsy report
• Flow cytometry
• Immunohistochemistry
• Cytogenetic reports
• Molecular/genetic testing
• PET-CT/CT/MRI reports where applicable
• Lymph-node biopsy
• Histopathology
• Previous chemotherapy records
• Previous transplant records
• Current medication list
• Blood-transfusion history
• Previous treatment-response reports

The Indian specialist may then provide

• Preliminary medical opinion
• Recommended additional investigations
• Suggested treatment approach
• Transplant assessment
• Cellular-therapy assessment where appropriate
• Approximate treatment timeline
• Approximate cost
• Expected hospitalization

The treatment plan may change after the patient reaches India and diagnostic tests are reviewed or repeated.

Q7 · Can Nigerian Patients Get a Second Opinion for Leukemia or Lymphoma in India?

Yes.

A second opinion can be especially useful when

• The diagnosis is complex
• The disease has relapsed
• Initial treatment has not produced the expected response
• A transplant has been recommended
• CAR-T therapy is being considered
• The family wants to compare treatment options
• There is uncertainty about the diagnosis or molecular classification

A second opinion may review

• Exact cancer subtype
• Risk classification
• Molecular profile
• Bone-marrow findings
• Previous treatment
• Treatment response
• Relapsed or refractory disease
• Transplant eligibility
• Donor options
• CAR-T eligibility
• Alternative treatment strategies

Patients should provide complete original reports wherever possible.

Q8 · What Medical Records Should Patients Take Home After Blood Cancer Treatment?

Patients should maintain a complete medical file for future treatment and follow-up in Nigeria.

Important records include

• Final diagnosis
• Histopathology report
• Bone-marrow biopsy report
• Flow cytometry report
• Molecular and cytogenetic reports
• PET-CT/CT/MRI reports
• Chemotherapy protocol
• Drug names and doses
• Targeted therapy details
• Immunotherapy details
• Radiation-treatment summary
• Transplant report
• Donor/HLA information where applicable
• CAR-T treatment records where applicable
• Discharge summary
• Current medication list
• Follow-up schedule
• Response assessment
• Recommended blood tests

Patients should keep both physical and digital copies of important records.

Q9 · What Advanced and Technology-Assisted Blood Cancer Treatments Are Available in India?

Modern Indian hematology centres may offer several advanced treatment approaches.

1. Molecular and Genetic Testing

Molecular and cytogenetic testing can help classify blood cancers and identify abnormalities that may influence treatment.

2. Targeted Therapy

Targeted medicines may be used when the cancer contains a specific molecular or biological target.

3. Immunotherapy

Selected leukemia and lymphoma patients may receive antibody-based or other immune-directed treatments.

4. Stem-Cell / Bone-Marrow Transplantation

Depending on the disease, patients may be considered for:

• Autologous transplantation
• Allogeneic transplantation
• Matched-related transplantation
• Matched-unrelated transplantation
• Haploidentical transplantation

CAR-T Cell Therapy

CAR-T therapy is a specialized cellular treatment used for selected relapsed or refractory blood cancers.

India has developed and expanded access to indigenous CAR-T therapies for selected B-cell leukemia and lymphoma patients.

Advanced Supportive Care

Specialized centres may also provide:

• Blood and platelet transfusion
• Infection management
• Intensive-care support
• Nutritional support
• Transfusion medicine
• Treatment of chemotherapy-related complications

Not every advanced treatment is appropriate for every patient. Eligibility must be determined by the treating hematology team.

Q10 · Does Nigerian Health Insurance or Travel Insurance Cover Blood Cancer Treatment in India?

Patients should check their insurance policy before travelling.

Important questions include

• Is overseas cancer treatment covered?
• Is treatment in India covered?
• Are chemotherapy medicines covered?
• Are targeted medicines covered?
• Is immunotherapy covered?
• Is bone-marrow transplantation covered?
• Is CAR-T therapy covered?
• Are complications covered?
• Is ICU treatment covered?
• Are medicines after discharge covered?
• Are pre-existing conditions excluded?
• Are travel and accommodation covered?

Patients should also plan financially for unexpected costs such as

• Prolonged hospitalization
• Infection
• ICU care
• Additional chemotherapy
• Blood or platelet transfusions
• Treatment-related complications
• Additional diagnostic tests
• Change in treatment protocol
• Delayed discharge
• Extended accommodation

A written insurance confirmation is preferable before travelling.

Q11 · Can Blood Cancer Treatment Be Combined or Staged During One Trip?

Yes, but the treatment journey varies significantly according to the diagnosis.

Stage 1 — Diagnosis and Assessment

The patient may undergo

• Hematologist consultation
• Blood tests
• Bone-marrow examination
• Flow cytometry
• Molecular testing
• Imaging
• Pathology review

Stage 2 — Initial Treatment

Depending on the disease

• Chemotherapy
• Targeted therapy
• Immunotherapy
• Radiation therapy
• Supportive treatment

Stage 3 — Transplant Preparation

For selected patients

• Donor evaluation
• HLA testing
• Stem-cell collection
• Conditioning therapy
• Infection screening
• Organ-function assessment

Stage 4 — Stem-Cell Transplantation

The patient may undergo

• Stem-cell infusion
• Intensive monitoring
• Infection prevention
• Blood-product support
• Management of transplant complications

Stage 5 — Cellular Therapy

Selected patients may undergo cellular therapy such as CAR-T after specialist assessment and eligibility confirmation.

Stage 6 — Follow-Up

Patients require continued monitoring after returning to Nigeria.

Because treatment can be prolonged, patients should not book a short return trip without receiving a medical estimate from the treating team.

Q12 · What About the Indian Medical Visa, Flights and Hospital Admission?

Nigerian patients travelling to India for blood cancer treatment should arrange their medical travel carefully.

Before travelling, patients should generally arrange

• Valid passport
• Appropriate Indian medical visa
• Hospital appointment
• Hospital treatment documentation
• Medical records
• Current medication list
• Previous treatment records
• Accommodation
• Flight arrangements
• Financial arrangements
• Insurance review

Patients with severe anemia, very low blood counts, active infection or other serious complications should discuss flight safety with their treating doctor before travelling.

Hospital admission may be required immediately for patients with

• Severe infection
• Very low blood counts
• Serious bleeding
• Severe anemia
• Acute complications
• Other unstable medical conditions

Q13 · How Long Do Nigerian Patients Need to Stay in India and When Can They Fly Home?

The required stay depends on the treatment.

1. Diagnostic Evaluation

Initial evaluation may require several days depending on the investigations required.

2. Chemotherapy

Some chemotherapy may be administered through day-care services, while intensive protocols may require hospitalization.

3. Stem-Cell Transplantation

Transplant patients generally require a substantially longer stay because of conditioning, stem-cell infusion, blood-count recovery and monitoring for infection and other complications.

4. CAR-T Therapy

CAR-T therapy may also require prolonged monitoring because of potential treatment-related complications.

5. Before Flying Home

The treating team may consider:

• Blood counts
• Hemoglobin
• Platelet count
• Infection status
• General strength
• Treatment complications
• Medication requirements
• Need for frequent monitoring

Patients should not assume that hospital discharge automatically means they are fit to fly.

The treating doctor should provide travel and follow-up advice before returning to Nigeria.

Q14 · How Can Nigerian Patients Continue Follow-Up After Returning Home?

Blood cancer treatment frequently requires long-term monitoring.

After returning to Nigeria, follow-up may include

• Complete blood counts
• Kidney and liver-function tests
• Disease-specific molecular monitoring
• Imaging when required
• Medication monitoring
• Infection monitoring
• Transplant follow-up
• Long-term cancer surveillance

For Transplant Patients

Follow-up may include:

• Immunosuppressive medication monitoring
• Infection prevention
• Graft-versus-host disease monitoring after allogeneic transplantation
• Blood-count monitoring
• Organ-function monitoring
• Disease surveillance

For CAR-T Patients

The treating team may provide specific instructions regarding:

• Blood tests
• Infection monitoring
• Disease-response assessment
• Delayed treatment complications
• Follow-up consultations

Before returning home, patients should obtain

• Complete discharge summary
• Treatment summary
• Medication list
• Follow-up schedule
• Recommended laboratory tests
• Warning signs
• Emergency instructions
• Contact information for the treating hospital

Coordination between the Indian specialist and a hematologist in Nigeria can help maintain continuity of care.

Q15 · Should Nigerian Patients Choose Blood Cancer Treatment in Nigeria or India?

There is no single answer for every patient.

The decision should be based on

• Exact diagnosis
• Disease stage
• Molecular profile
• Previous treatment
• Treatment response
• Specialist availability
• Transplant requirement
• Cellular-therapy availability
• Hospital infrastructure
• Infection-control facilities
• Total treatment cost
• Travel requirements
• Long-term follow-up arrangements

India May Be Considered When

• A highly specialized hematology opinion is required
• Advanced molecular testing is needed
• Stem-cell transplantation is being considered
• The disease has relapsed or become refractory
• CAR-T therapy is being evaluated
• Pediatric blood cancer expertise is required
• Complex multidisciplinary treatment is needed
• The family wants an international specialist assessment

Nigeria May Be More Convenient When

• The required treatment is available locally
• The patient's condition makes international travel difficult
• Long-term monitoring can be provided effectively near home
• Emergency medical support close to home is particularly important
• The patient already has an established hematology team

A Practical Approach for Nigerian Patients

A practical first step is to send complete medical records to an experienced Indian hematology or hemato-oncology centre.

The specialist can then assess

• The exact diagnosis
• Disease risk and stage
• Previous treatment
• Recommended treatment options
• Whether transplantation may be required
• Whether cellular therapy may be appropriate
• Expected treatment timeline
• Approximate total cost
• Expected duration of stay
• Follow-up requirements after returning to Nigeria

The final decision should be made together with qualified hematology specialists after complete medical evaluation.

Nigerian Patient Pre-Travel Checklist

Patients

Medical Documents

• Passport copies
• Complete blood-count reports
• Peripheral blood smear
• Bone-marrow aspiration report
• Bone-marrow biopsy report
• Flow cytometry report
• Immunohistochemistry report
• Cytogenetic reports
• Molecular/genetic reports
• PET-CT/CT/MRI reports
• Lymph-node biopsy report, if applicable
• Previous chemotherapy records
• Previous transplant records, if applicable
• Current medication list
• Blood-transfusion records
• Previous discharge summaries

Travel Planning

• Indian medical visa
• Hospital appointment
• Treatment confirmation
• Flight arrangements
• Accommodation
• Accompanying attendant/family member
• Financial arrangements
• Insurance review
• Copies of all medical records

Questions to Ask the Indian Hematology Team

• What is the exact blood cancer diagnosis?
• What is the disease risk category?
• What additional tests are required?
• What treatment is recommended?
• Is chemotherapy required?
• Is targeted therapy or immunotherapy appropriate?
• Is a stem-cell transplant required?
• Is a donor required?
• Is CAR-T therapy appropriate?
• How long may treatment take?
• How long should the patient stay in India?
• What is included in the quotation?
• What additional costs may occur?
• How will follow-up be managed after returning to Nigeria?

Final Note

Leukemia, lymphoma, multiple myeloma and other blood cancers require specialized and individualized medical care. Treatment may range from chemotherapy and targeted medicines to immunotherapy, stem-cell transplantation and advanced cellular therapies. Nigerian patients considering treatment in India should obtain a specialist hematology opinion based on their complete medical records before making travel and financial arrangements. The complete treatment journey should be evaluated—including diagnosis, molecular testing, treatment, hospitalization, medicines, transplantation or cellular therapy where appropriate, complications, recovery, travel and long-term follow-up—rather than comparing the treatment price alone. This guide is for educational and medical-tourism planning purposes only and does not replace consultation with a qualified hematologist, hemato-oncologist, transplant specialist or treating hospital.

Page Summary

This page answers 15 frequently asked questions about leukemia, lymphoma and blood cancer treatments in India for Nigerian patients. It covers why patients travel for treatment, an indicative Nigeria-versus-India cost comparison, the Indian cities and hospitals to consider, the treatment and surgical options available, how to obtain a quotation remotely, second opinions, advanced options, recovery, unexpected costs, combining treatments, medical visa and travel planning, length of stay, follow-up after returning to Nigeria, and a complete pre-travel checklist.